PrecisionMed Conference is an unrivalled opportunity for healthcare providers, researchers, public sector buyers and influencers and others from across this eco-system within the Gulf Cooperative Council, to attend as delegates and catch up on latest developments, opportunities and outcomes within this dynamic area of disease prevention, diagnostics and treatment.
Day 1 | 24 May 2022
*This is a preliminary programme with ongoing updates.
| Time | Session | Session Title | Speaker (s) |
| 8:00-9:00 | Registration and Mixer | ||
| 9:00-9:10 | Opening Remarks | David Stradling, Event Director, PMES 2022 | |
| 9:10-9:20 | Welcome Remarks | ||
| 9:20-10:00 | Plenary Talk | Past, Present and Future of Precision Medicine (Need the final title of the talk) | Heidi Rehm PhD, Chief Genomics Officer, Department of Medicine, MGH; Co-Director, Medical and Population Genetics, Broad Institute; Medical Director, Broad Institute Clinical Research Sequencing Platform; Professor of Pathology, Harvard Medical School |
| 10:00-11:50 | Session I | ||
| 10:00-10:30 | Keynote Speech | Telomere to Telomere: A Complete Human Genome | TBD |
| 10:30-10:50 | Genome Guided Therapy; The Medicine of Tomorrow, Today | George P Patrinos, Professor of Pharmacogenomics and Pharmaceutical Biotechnology, University of Patras | |
| 10:50-11:10 | Enablers of Genomic Science for Precision Medicine | Min S. Park CSO, Sanimed International, Abu Dhabi | |
| 11:10-11:30 | TBD | ||
| 11:30-11:50 | Clinical Pharmacogenomics Implementation : Challenges and Opportunities | Mohamed Nagy H, Head of Personalized Medication Management, CCHE | |
| 11:50-13:00 | Lunch | ||
| 13:00-17:30 | Session II | New Trends in Precision Medicine in 2022 | |
| 13:00-13:30 | Keynote Speech | Leveraging Data from Individuals to Populations for Accelerated Drug Discovery and Development | Howard Jacob, Vice President of Genomics Research and Head of Data Integration, AbbVie |
| 13:30-14:15 | Panel Discussion | G42 | Dr Walid Zaher, Chief Research Officer, G42 Healthcare |
| Dr Sally Mahmoud, Lab Director, Biogenix Labs | |||
| Patrick Merel, Genomics Consultant, G42 Healthcare | |||
| Shameer Khader, PhD, Senior Director of Advanced Analytics, Data Science, and Bioinformatics, AstraZeneca | |||
| 14:15-14:30 | |||
| 14:30-15:30 | Lunch | ||
| 15:30-16:00 | |||
| 16:00-17:30 | Session II | New Trends in Precision Medicine in 2022 | |
| 16:00-16:15 | Panel Discussion | G42 Panel Discussion: | |
| 16:15-16:30 | |||
| 16:30-16:45 | Panel Discussion | Thermo Fisher Scientific Panel Discussion - The Use of Oncomine Solutions in Personalized Medicine and Research | |
| 16:45-17:00 | Tea Break and Mixer | ||
| 17:00-17:15 | Session III | ||
| 17:15-17:30 | |||
| 4:15-4:30 | |||
| 4:30-4:45 | |||
| 4:45-5:00 | |||
| 5.00-5.15 | |||
| 5.15-5.30 | |||
Day 2 | 25 May 2022
*This is a preliminary programme with ongoing updates.
wpDataTable with provided ID not found!
